by Cameron Scott, Singularity Hub
With a brain-stimulating procedure to relieve Parkinson’s disease and epilepsy and another that purports to prevent Alzheimer’s disease, it was only a matter of time before neurostimulation became an accepted treatment for migraine headaches, which affect about 1 in 10 people worldwide.
The FDA recently approved an external device that uses nerve stimulation to decrease the frequency of debilitating migraine headaches. The Cefaly headband, which connects to a stick-on electrode to stimulate the endings of the trigeminal nerve, is the first non-pharmaceutical treatment for chronic migraines to get the agency’s okay.
“Cefaly provides an alternative to medication for migraine prevention. This may help patients who cannot tolerate current migraine medications for preventing migraines or treating attacks,” Christy Foreman, director of device evaluation at the FDA’s Center for Devices and Radiological Health, said in a statement.
© 2014 Singularity Education Group